But missing a malignant tumor 0.0001% of the time is unacceptable, because it spikes the hospital's malpractice costs.
Meanwhile, in every country that isn't America, tumor detection rates go up, cancer outcomes improve, and the cost of delivery falls.
Americans continue to claim their system of funding insurance company profits rather than actual healthcare is best.